CSF PROTEIN INCREASED side effect
What is CSF PROTEIN INCREASED ?Drugs associated with CSF PROTEIN INCREASED
BETASERON CHANTIX CYCLOPHOSPHAMIDE CYCLOSPORINE DEXAMETHASONE ESCITALOPRAM MYLOTARG NAGLAZYME NATALIZUMAB OMNIPAQUE PEVARYL PROGRAF VINCRISTINE VIRAFERONPEG ZOMETACSF PROTEIN INCREASED : Pevaryl Side Effects Report #5630718-4
Physician from DENMARK reported PEVARYL problem on Feb 11, 2008. Female patient, weighting 123.5 lb, was diagnosed with vulvovaginal mycotic infection and was treated with PEVARYL. After drug was administered, patient experienced the following problems/side effects: csf protein increased, csf white blood cell count positive, mononeuritis, paraesthesia, peripheral coldness, rash, sensory loss, thrombocythaemia, . PEVARYL dosage: unknown. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Natalizumab Side Effects Report #5577888-4
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on Dec 19, 2007. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: csf protein increased, fatigue, multiple sclerosis relapse, nervous system disorder, neuromyelitis optica, pneumonia, quadriplegia, spinal cord disorder, urinary tract infection, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with LEVOXYL, BONIVA, AMBIEN, NOVANTRONE. Patient was hospitalized. Patient died on 07/01/2007.
CSF PROTEIN INCREASED : Omnipaque Side Effects Report #5420618-7
Physician from UNITED STATES reported OMNIPAQUE problem on Aug 09, 2007. Female patient, 59 years of age, was diagnosed with carotid artery disease and was treated with OMNIPAQUE. After drug was administered, patient experienced the following problems/side effects: csf protein increased, dystonia, gaze palsy, hemiparesis, nervous system disorder, posturing, . OMNIPAQUE dosage: unknown. During the same period patient was treated with FENTANYL, VALIUM, LIDOCAINE, LEVOTHYROXINE, ASPIRIN. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Naglazyme Side Effects Report #5591022-6
NAGLAZYME problem was reported by a Physician from BRAZIL on Dec 26, 2007. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with NAGLAZYME. After drug was administered, patient experienced the following problems/side effects: arthropathy, csf protein increased, disease progression, meningeal disorder, myelopathy, nuclear magnetic resonance imaging brain abnormal, spinal cord compression, . NAGLAZYME dosage: 1.5 ML; QM; INTH; 15 MG; X1; IV. Patient recovered.
CSF PROTEIN INCREASED : Mylotarg Side Effects Report #5593176-4
Consumer or non-health professional from UNITED STATES reported MYLOTARG problem on Jan 15, 2008. Male patient, weighting 196.7 lb, was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: csf protein increased, diarrhoea, guillain-barre syndrome, infection, muscle twitching, pyrexia, rash maculo-papular, . MYLOTARG dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ALLOPURINOL, CEFTAZIDIME, FLUCONAZOLE, TAZOCIN, VANCOMYCIN. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Prograf Side Effects Report #5601376-X
PROGRAF problem was reported by a Physician from UNITED STATES on Dec 21, 2007. Female patient, 44 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, csf protein increased, facial palsy, light chain analysis increased, . PROGRAF dosage: 3 MG, BID, ORAL; 1 MG, BID, ORAL. Patient recovered.
CSF PROTEIN INCREASED : Chantix Side Effects Report #5501656-2
Physician from UNITED STATES reported CHANTIX problem on Oct 26, 2007. Female patient, weighting 219.0 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, csf protein increased, feeling abnormal, headache, memory impairment, muscular weakness, paraesthesia, tremor, visual disturbance, . CHANTIX dosage: unknown. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Dexamethasone Side Effects Report #5409909-3
DEXAMETHASONE problem was reported by a Health Professional from UNITED KINGDOM on Aug 02, 2007. Female patient, 40 years of age, was diagnosed with hodgkin's disease and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: csf glucose increased, csf protein increased, febrile neutropenia, malignant neoplasm progression, metastasis, pleocytosis, . DEXAMETHASONE dosage: unknown. During the same period patient was treated with DOXORUBICIN, BLEOMYCIN, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, METHOTREXATE, PREDNISONE. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Betaseron Side Effects Report #5431744-0
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Aug 22, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, csf protein increased, dysarthria, dyskinesia, motor dysfunction, tremor, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Cyclosporine Side Effects Report #5432532-1
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Aug 27, 2007. Male patient, 56 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: csf cell count increased, csf protein increased, diarrhoea, electroencephalogram abnormal, grand mal convulsion, intubation, lung infiltration, mechanical ventilation, mental status changes, . CYCLOSPORINE dosage: 100 MG, QD. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PREDNISONE, DACLIZUMAB. Patient was hospitalized. Patient died on 11/18/2005.
CSF PROTEIN INCREASED : Viraferonpeg Side Effects Report #5616645-7
Physician from FRANCE reported VIRAFERONPEG problem on Jan 25, 2008. Male patient, 54 years of age, was diagnosed with hepatitis c and was treated with VIRAFERONPEG. After drug was administered, patient experienced the following problems/side effects: angiogram abnormal, beta globulin increased, csf protein increased, demyelination, depression, eye oedema, ischaemic neuropathy, nuclear magnetic resonance imaging brain abnormal, optic neuritis retrobulbar, . VIRAFERONPEG dosage: 800 MG MCG; QW; SC; 150 MCG; QW; SC. During the same period patient was treated with REBETOL. Patient was hospitalized and became disabled. Patient recovered.
CSF PROTEIN INCREASED : Escitalopram Side Effects Report #5570061-5
ESCITALOPRAM problem was reported by a Health Professional from FRANCE on Nov 29, 2007. Female patient, 60 years of age, was diagnosed with depression, anxiety and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, csf protein increased, dyskinesia, fall, gait disturbance, grand mal convulsion, hallucination, . ESCITALOPRAM dosage: unknown. During the same period patient was treated with NOCTRAN, MEPRONIZINE, ZOLPIDEM, ZOCOR, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Zometa Side Effects Report #5524930-2
Physician from SPAIN reported ZOMETA problem on Nov 16, 2007. Male patient was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, csf protein increased, dementia, muscle contractions involuntary, . ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with PAMIDRONATE DI. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Zometa Side Effects Report #5526219-4
ZOMETA problem was reported by a Physician from SPAIN on Nov 16, 2007. Male patient was diagnosed with prostate cancer and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, csf protein increased, dementia, muscle contractions involuntary, . ZOMETA dosage: 4 MG, QMO. During the same period patient was treated with PAMIDRONATE DI. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Cyclophosphamide Side Effects Report #5449145-8
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Sept 04, 2007. Male patient, 51 years of age, was diagnosed with b-cell lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: areflexia, asthenia, csf protein increased, dysphagia, guillain-barre syndrome, lymphocyte count decreased, paraesthesia, pyrexia, quadriparesis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, METHYLPREDNISOLONE, RITUXIMAB. Patient was hospitalized. Patient recovered.
CSF PROTEIN INCREASED : Vincristine Side Effects Report #5451829-2
VINCRISTINE problem was reported by a Physician from ITALY on Aug 31, 2007. Male patient, 51 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, condition aggravated, csf protein increased, dysphagia, guillain-barre syndrome, lymphocyte count decreased, white blood cell count decreased, . VINCRISTINE dosage: (1.4 MG/M2). During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, METHYLPREDNISOLONE, RITUXIMAB. Patient recovered.